Since 2000, GAVI has contributed to the immunisation of an additional 440 million children and the prevention of approximately 6 million future deaths.
Since 2000, Gavi has contributed to the immunisation of an additional 500 million children and the prevention of approximately 7 million future deaths.
More than half of these participants (64.9%, n = 146) considered themselves at least partly responsible for dengue prevention, leaving approximately one-third believing that they were not in any way responsible for dengue prevention.
The centre for disease control and prevention estimated that approximately 1.4 million cases of salmonellosis were annually reported in the United States [ 14].
A priori, we expected to observe an association of similar size for secondary prevention (rate ratio of approximately 1.15), based on the existing meta-analyses conducted in patients receiving statins for primary and secondary prevention.
Although some cervical abnormalities might have been underestimated, the total annual cost of cervical cancer prevention in Italy is approximately €181.5 million, of which 87% is attributable to screening.
If everyone adopted the prevention strategies as outlined, approximately 221 million life-years and 244 million quality-adjusted life-years could be added to adults in the United States over the next 30 years [ 18].
The massive public health response to these events included an unprecedented prevention program in which approximately 10,000 persons across the eastern United States were offered >60 days of postexposure antimicrobial prophylaxis to prevent inhalational anthrax (2).
There are approximately 188 overdose prevention programs in the United States that are distributing naloxone to drug users and their family members, but this does not seem to be proportionate to the magnitude of the epidemic.
Although 100% implementation of all 11 measures reviewed would decrease the $9.5 trillion cost of caring for CVD, diabetes, and congestive heart failure over the next 30 years by approximately $900 billion, the prevention activities themselves would cost $8.5 trillion, thus increasing total medical costs by some $7.6 trillion.
The total expenditure on health goods and services in Australia in FY2009-10 has been estimated at $121.4 billion by the AIHW, [ 37] and therefore our estimate suggests that secondary prevention with cervical screening comprises approximately 0.16% of the health-related expenditure in Australia.
